Viewing Study NCT00933361


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2026-02-06 @ 3:28 AM
Study NCT ID: NCT00933361
Status: COMPLETED
Last Update Posted: 2017-08-01
First Post: 2009-07-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Sponsor: Cantonal Hospital of St. Gallen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Cachexia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adult View